{
    "Trade/Device Name(s)": [
        "D3 FastPoint L-DFA Respiratory Virus Identification Kit"
    ],
    "Submitter Information": "Diagnostic Hybrids, Inc.",
    "510(k) Number": "K091171",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061101",
        "K081928",
        "K090073"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OMG",
        "LKT",
        "GNX",
        "GQS",
        "GNY",
        "GNW"
    ],
    "Summary Letter Date": "September 2, 2009",
    "Summary Letter Received Date": "September 8, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3980",
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay",
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A virus",
        "Influenza B virus",
        "Respiratory syncytial virus",
        "Human metapneumovirus",
        "Adenovirus",
        "Parainfluenza virus type 1",
        "Parainfluenza virus type 2",
        "Parainfluenza virus type 3"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab",
        "Nasal aspirate",
        "Nasopharyngeal aspirate",
        "Nasal wash",
        "Nasopharyngeal wash"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Fluorescence microscope"
    ],
    "Method(s)/Technology(ies)": [
        "Direct fluorescent antibody (DFA)",
        "Immunofluorescence"
    ],
    "Methodologies": [
        "Monoclonal antibody-based immunofluorescent detection"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Control Slides",
        "Buffer"
    ],
    "Document Summary": "FDA 510(k) summary for D3 FastPoint L-DFA Respiratory Virus Identification Kit for qualitative identification of multiple respiratory viruses using immunofluorescence in nasal and nasopharyngeal specimens.",
    "Indications for Use Summary": "Qualitative identification of influenza A, influenza B, respiratory syncytial virus, human metapneumovirus, adenovirus, and screening for parainfluenza viruses 1, 2, and 3 in nasal/nasopharyngeal swabs and aspirates/washes from patients with respiratory infection symptoms using direct detection immunofluorescence.",
    "fda_folder": "Microbiology"
}